Cross‐Scale Drug Delivery of Diatom Microrobots Based on A Magnetic Continuum Robot for Combined Chemical and Photodynamic Therapy of Glioblastoma

Mengyue Li,Junfeng Wu,Na Li,Junjian Zhou,Wen Cheng,Anhua Wu,Lianqing Liu,Niandong Jiao
DOI: https://doi.org/10.1002/adfm.202402333
IF: 19
2024-04-03
Advanced Functional Materials
Abstract:A magnetic continuum robot (MCR) is to be used to deliver optical fibers and microrobots to realize chemical and photodynamic therapy treatment of GBM. It can avoid the limitations of light penetration and the blood‐brain barrier to achieve intracranial drug delivery. The delivery method may expand the drug selectivity for GBM treatment and provide a new possibility for intracranial photodynamic therapy. Micro/nanorobots with active movement capabilities provide a new option for the treatment of glioblastoma (GBM). However, the long working distance of intravenous injection and the protection of the blood‐brain barrier can prevent micro/nanorobots from reaching the target location. Photodynamic therapy (PDT) has gradually appeared in GBM treatment research. The limitation of the penetrating strength of the light source will nevertheless hinder the application range of PDT. Herein, a magnetic continuum robot (MCR) to deliver optical fibers and microrobots for combined chemotherapy and PDT of GBM is used. The prepared magnetic diatom microrobots can effectively move in biological fluids and move upstream. Vacuum loading can improve the drug loading efficiency. The photosensitizer in the frustule cavity can be explosively released in a short time through ultrasound. The chemotherapeutic drugs have long‐term and pH‐sensitivity release characteristics. In vitro cell experiments showed that the combined administration of TMZ‐loaded microrobots and photosensitizer‐loaded microrobots has a synergistic effect. The in vitro model demonstrated that an MCR can deliver an optical fiber and drug‐loaded microrobots. This enables cross‐scale delivery of microrobots and deep PDT. This delivery method may expand the drug selectivity for GBM treatment and provide a new possibility for intracranial PDT.
materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology
What problem does this paper attempt to address?